nach oben

International Journal of Colorectal Disease

Erschienen in:

30.08.2019 | Original Article

The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307)

verfasst von: Kenichiro Toritani, Jun Watanabe, Yusuke Suwa, Shinsuke Suzuki, Kazuya Nakagawa, Hirokazu Suwa, Atsushi Ishibe, Mitsuyoshi Ota, Chikara Kunisaki, Itaru Endo

Erschienen in: International Journal of Colorectal Disease | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Aim

The aim of this retrospective study was to evaluate the frequency and risk factors of urinary dysfunction after autonomic nerve-preserving surgery for rectal cancer.

Methods

This was a retrospective multiinstitution study of 1002 rectal cancer patients conducted between January 2008 and December 2012 in Yokohama Clinical Oncology Group. Patients who had preoperative urinary dysfunction or had not undergone autonomic nerve preservation surgery were excluded. Urinary dysfunction was defined as that with a Clavien-Dindo classification grade ≥ 2. Patient-, tumor-, and surgery-related variables were examined by univariate and multivariate analyses.

Results

A total of 887 patients were analyzed. Postoperative urinary dysfunction was observed in 77 patients (8.8%). A multivariate logistic analysis showed that a tumor location in lower rectum (odds ratio [OR] 2.16; 95% confidence interval [CI] 1.15–3.71; p = 0.02), tumor diameter ≥ 40 mm (OR 2.07; 95% CI 1.19–4.44; p < 0.01), operation time ≥ 240 min (OR 2.07; 95% CI 1.19–4.44; p < 0.01), blood loss ≥ 300 ml (OR 2.35; 95% CI 1.12–3.84; p = 0.02), and diabetes (OR 3.26; 95% CI 1.80–5.89; p < 0.01) were independent risk factors of urinary dysfunction. The incidence of urinary dysfunction exceeded 20% in patients with 3 preoperative predictors (tumor location, tumor diameter, diabetes).

Conclusions

This result demonstrated that high-risk patients with more than two risk factors should be informed of the risk of urinary dysfunction.

Trial registration

UMIN000033688

Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 69(10):613–616CrossRefPubMed

MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet. 341(8843):457–460CrossRefPubMed

Nelso H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93(8):583–596CrossRef

Hojo K, Vernava AM 3rd, Sugihara K, Katumata K (1991) Preservation of urine voiding and sexual function after rectal cancer surgery. Dis Colon Rectum 34(7):532–539CrossRefPubMed

Moriya Y, Sugihara K, Akatsu T, Fujita S (1995) Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence. Dis Colon Rectum 38(11):1162–1168CrossRefPubMed

Kin C, Rhoads KF, Jalali M, Shelton AA, Welton ML (2013) Predictors of postoperative urinary retention after colorectal surgery. Dis Colon Rectum 56(6):738–746CrossRefPubMed

Lee SY, Kang SB, Kim DW, Oh HK, Ihn MH (2015) Risk factors and preventive measures for acute urinary retention after rectal cancer surgery. World J Surg 39(1):275–282CrossRefPubMed

Changchien CR, Yeh CY, Huang ST, Hsieh ML, Chen JS, Tang R (2007) Postoperative urinary retention after primary colorectal cancer resection via laparotomy: a prospective study of 2355 consecutive patients. Dis Colon Rectum 50(10):1688–1696CrossRefPubMed

Zmora O, Madbouly K, Tulchinsky H, Hussein A, Khaikin M (2010) Urinary bladder catheter drainage following pelvic surgery – is it necessary for that long? Dis Colon Rectum 53(3):321–326CrossRefPubMed

10.

Jang JH, Kang SB, Lee SM, Park JS, Kim DW, Ahn S (2012) Randomized controlled trial of tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery. World J Surg 36(11):2730–2737CrossRefPubMed

11.

Kang CY, Chaudhry OO, Halabi WJ, Nguyen V, Carmichael JC, Mills S, Stamos MJ (2012) Risk factors for postoperative urinary tract infection and urinary retention in patients undergoing surgery for colorectal cancer. Am Surg 78(10):1100–1104PubMed

12.

Burgos FJ, Romero J, Fernandez E, Perales L, Tallada M (1988) Risk factors for developing voiding dysfunction after abdominoperineal resection for adenocarcinoma of the rectum. Dis Colon Rectum 31(9):682–685CrossRefPubMed

13.

Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, Lim SB, Lee TG, Kim DY, Kim JS, Chang HJ, Lee HS, Kim SY, Jung KH, Hong YS, Kim JH, Sohn DK, Kim DH, Oh JH (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 11(7):637–645CrossRefPubMed

14.

Benoist S, Panis Y, Denet C, Mauvais F, Mariani P, Valleur P (1999) Optimal duration of urinary drainage after rectal resection: a ramdomized controlled trial. Surgery. 125(2):135–141CrossRefPubMed

15.

Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11):1663–1672CrossRefPubMed

16.

Fujita S, Yamamoto S, Akasu T, Moriya Y (2003) Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 90(12):1580–1585CrossRefPubMed

17.

Watanabe T, Muro K, Ajioka Y et al (2018) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol 23(1):1–34CrossRefPubMed

18.

Moriya Y, Sugihara K, Akasu T, Fujita S (1995) Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer. Eur J Cancer 31A(7–8):1229–1232CrossRefPubMed

19.

Mori T, Takahashi K, Yasuno M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbeck's Arch Surg 383(6):409–415CrossRef

20.

Maeda K, Maruta M, Utsumi T, Sato H, Toyama K, Matsuoka H (2003) Bladder and male sexual functions after autonomic nerve-sparing TME with or without lateral lymph node dissection for rectal cancer. Tech Coloproctol 7(1):29–33CrossRefPubMed

21.

Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786CrossRefPubMed

22.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral

23.

Saito N, Koda K, Nobuhiro K, Takiguchi K, Oda K, Soda H, Nunomura M, Sarashina H, Nakajima N (1999) Nerve-sparing surgery for advanced rectal cancer patients: special reference to Dukes C patients. World J Surg 23(10):1062–1068CrossRefPubMed

24.

Habib HN (1967) Experience and recent contributions in sacral nerve stimulation for voiding in both human and animal. Br J Urol 39(1):73–83 No abstract available CrossRefPubMed

25.

Lange MM, Maas CP, Marijnen CA et al (2008) Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial: urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 95(8):1020–1028CrossRefPubMed

26.

Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, Steers WD, van den Eeden SK, McVary KT (2005) Urologic complications of diabetes. Diabetes Care 28(1):177–185CrossRefPubMed

27.

Liu G, Daneshgari F (2014) Diabetic bladder dysfunction. Chin Med J 127(7):1357–1364PubMed

28.

Kyo K, Sameshima S, Takahashi M, Furugori T, Sawada T (2006) Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg 30(6):1014–1019CrossRefPubMed

29.

Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 10(11):1053–1062CrossRefPubMed

30.

Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44(9):1274–1280CrossRefPubMed

31.

Matsuoka H, Masaki T, Sugiyama M, Atomi Y (2005) Impact of lateral pelvic lymph node dissection on evacuatory and urinary functions following low anterior resection for advanced rectal carcinoma. Langenbeck's Arch Surg 390(6):517–522CrossRef

32.

Cöl C, Hasdemir O, Yalcin E et al (2005) The assessment of urinary function following extended lymph node dissection for colorectal cancer. Eur J Surg Oncol 31(3):237–241CrossRefPubMed

33.

Ito M, Kobayashi A, Fujita S et al (2018) Colorectal Cancer Study Group of Japan Clinical Oncology Group. Urinary dysfunction after rectal cancer surgery: results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212). Eur J Surg Oncol 44(4):463–468CrossRefPubMed

34.

Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y (2012) Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 13(6):616–621CrossRefPubMed

35.

Dulskas A, Samalavicius NE (2016) A prospective study of sexual and urinary function before and after total mesorectal excision. Int J Color Dis 31(6):1125–1130CrossRef

36.

Costanzi A, Rigamonti L, Mari GM, Miranda A, Crippa J, Berardi V, Maggioni D (2015) A prospective video-controlled study of genito-urinary disorders in 35 consecutive laparoscopic TMEs for rectal cancer. Surg Endosc 29(7):1721–1728CrossRefPubMed

37.

Pollack J, Holm T, Cedermark B, Altman D, Holmström B, Glimelius B, Mellgren A (2006) Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93(12):1519–1525CrossRefPubMed

38.

Peeters KC, van de Velde CJ, Leer JW et al (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol 23(25):6199–6206CrossRefPubMed

Titel: The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307)
verfasst von: Kenichiro Toritani
Jun Watanabe
Yusuke Suwa
Shinsuke Suzuki
Kazuya Nakagawa
Hirokazu Suwa
Atsushi Ishibe
Mitsuyoshi Ota
Chikara Kunisaki
Itaru Endo
Publikationsdatum: 30.08.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: International Journal of Colorectal Disease / Ausgabe 10/2019
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-019-03374-3

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Aim

Methods

Results

Conclusions

Trial registration

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2019

Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials

Ventral rectopexy with biological mesh for recurrent disorders of the posterior pelvic organ compartment

Predictive parameters for the clinical course of Crohn’s disease: development of a simple and reliable risk model

Treatment of complex recurrent fistula-in-ano by surgery combined to autologous bone marrow–derived mesenchymal stroma cells and platelet-rich plasma injection

Osseous metaplasia in a recurrent symptomatic rectal lesion: a rare occurrence

Disease phenotype rather than treatment strategy impacts the long-term quality of life in patients with diverticular disease

Update Chirurgie